SWITCHING BIOLOGICS AFTER INITIAL ANTI-TUMOUR NECROSIS FACTOR-alpha FAILURE; SUCCESS WITH FURTHER TNF-alpha ANTAGONISM BUT FAILURE ON SUBSEQUENT INTERLEUKIN-1 RECEPTOR ANTAGONISTM. H. Buch,S. J. Bingham,Y. Seto,V. Bejarano, M. Rynne, D. BryerRHEUMATOLOGY（2004）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
